We are excited to share that we will attend the 2026 European Hematology Association (EHA) Congress. We look forward to engaging with leading experts on the latest advancements and cutting-edge developments in hematology.

Don’t miss the opportunity to meet our delegates Bob Delise and Andrea Mantovani onsite to discuss your commercial and access strategies. We can support you with a range of strategic priorities, from differentiating your oncology pipeline for future success and maximum patient impact to designing your JCA preparedness roadmap as part of a broader, integrated market access strategy.